Physician profile
Thomas Hawkey
NPI 1043292618
$5,017.26
in general payments reported to CMS, 2019-2025
34 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $1,164 · 2021: $1,024 · 2022: $569 · 2023: $547 · 2024: $556 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,578.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $797.71 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $763.30 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $519.96 | 2019-2025 | Jardiance, Synjardy |
| Kowa Pharmaceuticals America, INC. | $363.68 | 2019-2024 | Livalo, Seglentis |
| Amarin Pharma, INC. | $322.50 | 2019-2022 | |
| Pfizer INC. | $298.39 | 2019-2024 | |
| Amgen INC. | $287.12 | 2019-2025 | Repatha, Krystexxa, Repatha |
| Lilly USA, LLC | $235.59 | 2020-2024 | Jardiance, Mounjaro, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $172.35 | 2022-2025 | |
| Esperion Therapeutics, INC. | $170.29 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $162.72 | 2021-2023 | |
| Abbott Laboratories | $157.43 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $154.15 | 2019-2024 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $109.89 | 2021-2024 | Veozah |
| Merck Sharp & Dohme LLC | $74.04 | 2019-2023 | Verquvo, Belsomra |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41.86 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $38.31 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $37.57 | 2022-2025 | Eliquis |
| Acadia Pharmaceuticals INC | $33.40 | 2025 | Nuplazid |
| Xeris Pharmaceuticals, INC. | $33.19 | 2022-2023 | Gvoke Hypopen |
| Daiichi Sankyo INC. | $29.78 | 2024 | Injectafer |
| Edwards Lifesciences Corporation | $23.43 | 2021 | |
| Viatris Specialty LLC | $21.81 | 2025 | Yupelri |
| Vital Connect, INC | $20.51 | 2023 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $20.00 | 2021 | |
| Ironwood Pharmaceuticals, INC | $19.55 | 2020 | |
| Shield Therapeutics INC | $17.24 | 2024 | |
| Eisai INC. | $14.78 | 2021 | |
| Mylan Specialty L.P. | $14.66 | 2020 | |
| Horizon Therapeutics Plc | $13.73 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.25 | 2023 | Quviviq |
| Currax Pharmaceuticals LLC | $13.03 | 2019 | |
| Hikma Pharmaceuticals USA | $11.05 | 2020 | |
| Allergan, INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hawkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.